Research Article
New Biomarkers to Predict the Evolution of In Situ Breast Cancers
Table 2
Expression of different markers in tumor cells and stroma in relapsed and nonrelapsed patients.
| Markers | Overall series | | G1 + G2 | G3 | Nonrelapsed (median, range) | Relapsed (median, range) | P | Nonrelapsed (n = 17) (median, range) | Relapsed (n = 6) (median, range) | P | Nonrelapsed (n = 15) (median, range) | Relapsed (n = 6) (median, range) | P |
| TG2 | | | | | | | | | | Tumor cells | 15 (0–100) | 3 (0–80) | 0.306 | 20 (0–100) | 11.5 (0–70) | 0.532 | 10 (0–70) | 2.5 (0–80) | 0.463 | Stroma | 100 (0–100) | 100 (70–100) | 0.413 | 100 (20–100) | 100 (70–100) | 0.929 | 100 (0–100) | 100 (100-100) | 0.206 | HJURP | | | | | | | | | | Tumor cells | 3 (0–90) | 8 (0–100) | 0.555 | 2 (0–90) | 80 (0–100) | 0.063 | 10 (0–80) | 0 (0–70) | 0.192 | Stroma | 0 (0–70) | 0 (0–80) | 0.347 | 0 (0–70) | 55 (0–80) | 0.031 | 0 (0–70) | 0 (0–3) | 0.225 | HIF-1α | | | | | | | | | | Tumor cells | 0 (0–10) | 1 (0–70) | 0.137 | 0 (0–10) | 0 (0-0) | 0.439 | 0 (0–10) | 7.5 (2–70) | 0.024 | Stroma | 0 (0–2) | 0 (0–10) | 0.096 | 0 (0–2) | 0 (0–10) | 0.753 | 0 (0–2) | 2 (0–10) | 0.019 |
|
|